Aspect Partners »

Dyne Therapeutics shares owned by Aspect Partners

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Aspect Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 725 35.92
2024-06-30 $26k 725 35.29
2024-03-31 $21k 725 28.39
2023-12-31 $9.6k 725 13.30

More positions owned by Aspect Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Total Stock Market Etf Etf (VTI)
Spdr Gold Shares Etf (GLD)
Ishares U.s. Real Estate Etf Etf (IYR)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Return Stacked Global Stocks & Bonds Etf Etf (RSSB)
Real Estate Select Sector Spdr Fund Etf (XLRE)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Vanguard International Dividend Appreciation Etf Etf (VIGI)
Distillate Small/mid Cash Flow Etf Etf (DSMC)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)

View all positions for Aspect Partners

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics